Investigational New Drug Application and Approval Process
Main Article Content
Abstract
ABSTRACT
The investigational new drug (IND) application is the result of a successful preclinical development program. The IND is also the vehicle through which a sponsor advances to the next stage of drug development known as clinical trials (human trials). This article will focus the approval process of investigational new drug & its approval by regulatory bodies.IND Application is the precursor of NDA Process. This article, which emphasis on easy access to understanding how this agency (USFDA) operates with respect to practical aspect of IND & its approval process. USFDA establish process albeit need to improve IND Application process.
The investigational new drug (IND) application is the result of a successful preclinical development program. The IND is also the vehicle through which a sponsor advances to the next stage of drug development known as clinical trials (human trials). This article will focus the approval process of investigational new drug & its approval by regulatory bodies.IND Application is the precursor of NDA Process. This article, which emphasis on easy access to understanding how this agency (USFDA) operates with respect to practical aspect of IND & its approval process. USFDA establish process albeit need to improve IND Application process.
Downloads
Download data is not yet available.
Article Details
How to Cite
Menda, I. S. (2011). Investigational New Drug Application and Approval Process. International Journal of Pharmaceutical & Biological Archive, 2(4). Retrieved from https://ijpba.info/index.php/ijpba/article/view/334
Section
Review Articles
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.